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Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory airway disease involving non-eosinophilic 
and eosinophilic phenotypes, which translate to various endotypes. Activated eosinophils and 
neutrophils are known to generate extracellular traps consisting of DNA and cytotoxic granule 
proteins. We sought to investigate the presence of eosinophil and neutrophil extracellular traps 
(EETs and NETs, respectively) in human CRS tissues and to clarify the associations with their clinical 
features. Nasal polyp (NP) or ethmoid tissue slides of 43 subjects from endoscopic sinus surgery for 
CRS were analysed. Quantitative analysis of EETs and NETs was performed by confocal microscopy 
using immunofluorescent staining. For correlation study, the presence of NPs, number of infiltrating 
tissue eosinophils, preoperative Lund–Mackay scores, and other comorbidities were analysed. EET 
formation was observed to varying degrees in all CRS groups and was correlated with the number of 
tissue eosinophils (r  =  0.83, p  < 0.001) regardless of the presence of NPs. Patients with more EETs 
demonstrated higher Lund–Mackay scores (r =  0.51, p = 0.009), blood eosinophilia (r =  0.80, p < 0.001), 
and decreased olfactory function (r = −0.65, p < 0.001). No correlation between the extent of EET 
formation and the presence of atopy or asthma was apparent. However, none of the CRS groups 
containing neutrophils formed NETs in this study. Eosinophilic CRS indicates the presence of EETs. 
Formation of EETs could have a role in clinical decision-making and prediction of treatment outcome of 
CRS, regardless of NP status.
Chronic rhinosinusitis (CRS) is a common and challenging inflammatory disease that involves non-eosinophilic 
and eosinophilic phenotypes1–3. It is known that the latter is typically marked by a greater disease burden with 
respect to risk for comorbidities and the likelihood of recurrence after surgical intervention4,5. Likewise, it is 
more probable that patients with tissue eosinophilia will have nasal polyps (NPs) compared to patients without 
tissue eosinophilia6. However, there are no standard methods for evaluating tissue eosinophilia due to diversity in 
geographic conditions and uneven distribution within a tissue3,7. Eosinophilic NPs also show a variety of inflam-
matory cells, such as neutrophils and macrophages, that may play a role in the tissue remodelling process in NPs8. 
Therefore, there are limitations to the subtyping of CRS or NPs based only on inflammatory cells.
A previous study revealed that neutrophils are able to form extracellular structures containing DNA and 
granule proteins, so-called neutrophil extracellular traps (NETs)9. These novel structures are formed by activated 
neutrophils and can kill invading pathogens before they reach host cells, a phenomenon which was at the time of 
the study recognized as the third antimicrobial function of neutrophils following phagocytosis and secretion of 
soluble antimicrobials. Other, recent evidence has indicated that activated eosinophils show similar extracellular 
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structures, named eosinophil extracellular traps (EETs), which are able to bind and kill bacteria extracellularly10,11. 
Such extracellular nets are known to form in a reactive oxygen species (ROS)-dependent manner after priming 
with complement factor 5a, eotaxin, interferon-γ, interleukin (IL)-5, lipopolysaccharides, Staphylococcus aureus 
(S aureus), or thymic stromal lymphopoietin10,12,13. Although the mechanism continues to be disputed, their gen-
eration has such a distinct pathway from suicidal cell death that such cytolysis could be renamed extracellular trap 
cell death, so-called ETosis14,15.
In the early days, extracellular DNA trap was studied in infectious or autoimmune disease models; however, 
recently, it was also identified in noninfectious models, such as allergic diseases in relation to EETs11,16,17. For the 
first time, researchers in Belgium and Japan described the presence of EETs in IL-5+ NP and eosinophilic sinus 
secretion, respectively, from human eosinophilic CRS (ECRS) samples18,19. These data suggested that EETs can 
play either a beneficial or harmful role in the field of ECRS, as their increased presence is observed at the site of 
epithelial barrier defects. EET formation was directly induced on exposure to S aureus, which in turn was able 
to entrap the bacteria and facilitate a role in the host’s defense against microbes12. However, compared to NETs, 
EETs contain smaller amounts of protease that contribute to the stability and high viscosity of eosinophilic mucin, 
in turn impairing their clearance by inflammatory cells and antibiotics20. As a consequence, EETs might cause 
long-lasting adhesive luminal surfaces as postmortem functions, resulting in further compromise of the barrier 
dysfunction, along with more bacterial aggregation and growth of biofilms and the potential for reinfection and 
chronicity of disease.
Although EETs in inflamed foci might be involved in the pathogenesis of ECRS, there is a lack of research 
to date regarding non-ECRS and the aim of clinical correlation. Therefore, the purpose of the present study was 
to explore the presence and distribution of EETs in eosinophilic and non-eosinophilic human CRS tissues and 
to clarify the correlations between their quantifiable level and clinical features in patients with CRS. Notably, 
we observed NETs as well as EETs in this study because CRS involves various pathomechanisms showing high 
heterogeneity even in patients with ECRS with a dominant TH2 profile. In addition, the presence of NETs in CRS 
tissues is not yet known.
Methods
Subjects. The diagnosis of CRS was based on patient history, nasal endoscopy, and computed tomography 
(CT) according to a 2012 European position paper on rhinosinusitis and nasal polyps21. To qualify for inclusion 
in this study, subjects were required to (1) be over 19 years of age, (2) be refractory to medical treatment and thus 
require bilateral endoscopic sinus surgery, and (3) have data from a minimum follow-up period of six months. 
None of the subjects had taken any form of local or systemic corticosteroid for at least four weeks prior to the 
operation. In addition, patients were excluded if they had a history of mucociliary disorder or immunocom-
promised status. The present study was approved by the institutional review board (IRB) of Yonsei University 
College of Medicine (IRB no. 4-2017-0408). Informed consent was obtained from all individual participants 
prior to enrolment in the present study. All procedures performed in studies involving human participants were 
conducted in accordance with the ethical standards of the institutional and/or national research committee, and 
with the 1964 Helsinki declaration and its later amendments, or with comparable ethical standards.
Classification of CRS was based on the NP and the Japanese Epidemiological Survey of Refractory 
Eosinophilic Chronic Rhinosinusitis (JESREC) scoring systems4. According to the JESREC scoring system, four 
categories of preoperative clinical features were used to assess ECRS, as follows: (1) bilateral disease sites were 
given a score of 3; (2) presence of NP was given a score of 2; (3) a dominant shadow of ethmoid sinus on a CT 
scan was given a score of 2; and (4) eosinophilia in peripheral blood was given a score of either 4 (>2% and 
≤5%), 8 (>5% and ≤10%), or 10 (>10%). A JESREC score value higher than 11 points was determined to indi-
cate ECRS. Patients in the ECRS group were stratified into three subgroups according to severity (neither A or 
B = mild, A or B = moderate, A and B = severe) by adding the refractory score, as follows: (A) blood eosinophilia 
(>5%) and ethmoid-dominant shadow in CT; (B) comorbidity of bronchial asthma, aspirin, or nonsteroidal 
anti-inflammatory drug intolerance. Finally, 43 nasal tissues samples and five control tissues were classified into 
four groups and analysed with clinical parameters. The clinical and demographic data of the patients are summa-
rized in Table 1.
Sample collection. CRS biopsy tissues of 43 patients archived as 4% paraformaldehyde-fixed and 
paraffin-embedded samples obtained during routine functional endoscopic sinus surgery at Yonsei University 
Severance Hospital from January 2017 to December 2017 were analysed. Ethmoid tissues were obtained from 
CRS without NPs (n = 22), and NPs were obtained from CRS with NPs (n = 21). Additionally, inferior turbinates 
from five healthy subjects who were undergoing septal surgery because of anatomic deviations were collected as 
control tissues.
Assessment of medical conditions. For the correlation study, preoperative taste and smell tests, preop-
erative Lund–Mackay CT score22, as well as number of tissue eosinophils, comorbidities, and surgical outcomes 
were assessed. Using the recently developed gustatory function test (YSK taste function test kit, RHICO med-
ical Co., Seoul, Korea), the sum of recognition threshold for five tastants, including sweet, butter, salty, sour, 
and umami, was scored. Scores lower than 12 were considered to have hypogeusia, accordingly to previously 
described protocols23. Olfactory function test comprised the Korean version of Sniffin’ Stick II (KVSS II, Bughart, 
Wedel, Germany), and the sum of threshold, discrimination, and identification scores was defined as KVSS II 
score. KVSS II scores 0 to 20 were defined as “anosmia,” 20.25 to 27 as “hyposmia,” and 27.25 to 48 as “normos-
mia.” Such criteria were determined based on previous work24. Patients were considered to have allergy if the skin 
prick test was positive for at least one of the batteries of standardized aeroallergens in South Korea. Asthma was 
defined based on lung function analysis, including methacholine challenge testing.
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Immunofluorescent staining. EETs and NETs were identified as previously described12,13,17. EETs and 
NETs were visualized in 5-µm-thick sections of paraffin-embedded tissue slides by means of indirect immuno-
fluorescence, followed by counterstaining for DNA. The sections were blocked by 1% BSA, 1% normal donkey 
serum, then incubated with anti-eosinophil cationic protein (ECP) polyclonal antibody (Biolegend, San Diego, 
CA) and anti-myeloperoxidase (MPO) polyclonal antibody (R&D Systems, Minneapolis, MN), respectively. 
Alexa Fluor 568 and Alexa Fluor 488 (both Invitrogen, Carlsbad, CA) were used for secondary incubation, 
respectively. Negative controls were incubated with nonimmune serum instead of primary antibody. DNA was 
visualized with 4′6-diamino-2-phenylindole (Invitrogen, Carlsbad, CA). After washing with phosphate-buffered 
saline, the slides were mounted in a drop of fluorescent mounting medium (DAKO, Glostrup, Denmark). Images 
were obtained with a confocal laser scanning microscope (LSM 700; Carl Zeiss Microimaging, Jena, Germany) 
and analysed using ZEN software (Carl Zeiss, Jena, Germany). EET-positive cells were identified by cells that 
produced extracellular, decondensed DNA in fibers, or in a web-like shape colocalized with ECP11. Eosinophils 
and EETs were counted in 10 high-power fields (HPFs) as previously described16,17, and values are expressed as 
mean ± standard error of the mean (SEM) per HPF throughout the article. In analogy to EET, NET was defined 
that extracellular DNA released by neutrophils in conjunction with MPO in a fashion similar to the structures 
previously described in patients with asthma17. All assessments of images processing were performed by two 
independent investigators in a blinded manner (C.S.H. and S.C.P.).
Statistical analysis. For between-group comparisons, the Mann–Whitney U test or Kruskal–Wallis test 
with a two-tailed test was used. To describe the correlation between variables, linear correlation analysis was used 
to determine bivariate relationships with a Spearman correlation test. Data are expressed as mean ± SEM. All 
statistical analyses were conducted using the Statistical Package for the Social Sciences version 18.0 (IBM Corp., 
Armonk, NY). A p value < 0.05 was considered statistically significant.
Results
All groups had eosinophils that were found to form eosinophil extracellular traps in tis-
sues. EET-releasing eosinophils were observed in both the ECRS and non-ECRS groups. The confocal micros-
copy images clearly showed the presence of extracellular DNA nets in association with the granular protein ECP 
in the non-ECRS group (Fig. 1A). In the ECRS group, EET formation was more prominent (Fig. 1B). The num-
bers of EET-releasing eosinophils were highest in the apical part of the subepithelial region compared with those 
in the basal part or deep in the stroma. For the ECRS group, in the basal parts of the epithelium or deep in stroma, 
eosinophils were found to be mostly intact, and EET formation was very rare (Fig. 1C), whereas in the subepi-
thelial regions with single-cell layers and missing epithelial cells, eosinophils were often seen in clusters and were 
often released as massive and clustered EETs (Fig. 1D). However, none of the CRS groups containing neutrophils 
formed NETs in this study. Even in the non-ECRS tissues, where a high number of neutrophils exceeding the 
number of eosinophils was observed, NETs were not found in the subepithelial region or the stroma (Fig. 1E,F).
With respect to the quantifiable level of ECP-DNA complex in each individual CRS subtype, Fig. 2 shows a 
mean value of EET-releasing eosinophils per HPF. EETs were expressed as a mean value of eosinophils generating 
EETs relative to the total amount of those present in 10 HPFs. No EET-releasing eosinophils were found in the 
healthy control group.
Formation of eosinophil extracellular traps correlated with the number of tissue eosinophils 
regardless of the presence of nasal polyps. All surgical samples selected in this study were stained 
with haematoxylin and eosin. Eosinophils were observed rarely in the tissue of the control subjects. Although 
Characteristic
Non-ECRSsNP 
(n = 11)
Non-ECRSwNP 
(n = 10)
ECRSwNP 
(n = 11)
ECRSsNP 
(n = 11)
Control 
(n = 5)
Mean age, years 51.0 ± 9.1 48.1 ± 14.6 40.6 ± 14.5 45.0 ± 14.1 28.2 ± 9.8
Sex, M/F 8/3 7/3 4/7 5/6 5/0
BMI, kg/m2 25.1 ± 3.1 25.0 ± 3.2 23.3 ± 3.0 22.0 ± 1.8 23.7 ± 2.6
JESREC† 4.5 ± 2.1 7.4 ± 1.9 17.3 ± 1.3 15.9 ± 2.2 4.0 ± 0
LM score 11.5 ± 6.7 17.4 ± 4.5 19.2 ± 3.1 17.6 ± 5.6 0
KVSS II score 25.7 ± 7.6 13.8 ± 10.3 12.4 ± 8.8 19.2 ± 8.3 31.8 ± 2.6
IgE, KU/L 132.3 ± 93.2 47.0 ± 48.2 234.6 ± 153.9 165.3 ± 130.0 28.1 ± 21.5
Eosinophils in 
peripheral blood, % 1.9 ± 1.1 2.5 ± 1.4 10.9 ± 3.4 10.5 ± 3.6 2.2 ± 1.2
Allergy, −/+ 6/5 6/4 0/11 1/10 4/1
Asthma, −/+ 3/0 7/0 7/4 6/5 5/0
Aspirin (NSAIDs) 
intolerance, n 0 0 0 0 0
Table 1. Characterization of the study population. All continuous data are presented as mean ± standard 
deviation. †The sum of JESREC score and refractory score. Abbreviations: ECRS, eosinophilic chronic 
rhinosinusitis; NP, nasal polyp; ECRSsNP, ECRS without NPs; ECRSwNP, ECRS with NPs; BMI, body mass 
index; JESREC, Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis; LM, Lund–
Mackay; KVSS II, Korean Version of the Sniffin’ Stick test II; NSAIDs, nonsteroidal anti-inflammatory drugs.
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there were substantial differences between subjects, the ECRS group overall was infiltrated with a significantly 
higher number of tissue eosinophils than the non-ECRS group (53.6 ± 8.0 vs. 2.5 ± 0.6, p < 0.0001; Fig. E1). 
Moreover, the ECRS group demonstrated a significantly increased number of EET-releasing eosinophils versus 
the non-ECRS group (5.1 ± 0.5 vs. 0.6 ± 0.2, p < 0.0001; Fig. 3A). However, interestingly, EET formation was not 
associated with presence of polyps (3.6 ± 1.1 vs. 2.5 ± 0.6, p = 0.402; Fig. 3B), though EETs were correlated with 
total number of tissue eosinophils (r = 0.829, p < 0.0001, Fig. 3C). Considering all subjects, the mean fraction of 
EET-releasing eosinophils was 13.5% ± 8.8% (range: 0–35%) of the total amount of eosinophils infiltrating the 
nasal mucosa epithelium.
Eosinophil extracellular traps appear to reflect activated eosinophils with a greater disease 
burden. EET-releasing eosinophils showed correlations with some clinical features in patients with CRS. 
We observed a higher number of infiltrating EET-releasing eosinophils in CRS specimens from subjects with a 
Figure 1. Representative image of endoscopic sinus surgery specimens from CRS subjects showing EETs. (A) 
The extracellular DNA was colocalized with ECP (indicated by the arrowheads) in the non-ECRS without NPs 
group. Scale bar = 5 µm. (B) In the case of ECRS with NPs, EET formation was more prominent (indicated 
by the arrowheads). Scale bar = 5 µm. (C) For the ECRS group, eosinophils located deep in the stroma were 
found to have mostly intact granules, and EET formation was very rare. (D) EETs were found mainly in the 
subepithelial regions, with clusters of eosinophils underneath the epithelial barrier defect. Scale bar = 20 µm. 
However, none of the groups were found to form NETs, even with the increased presence and alignment of 
neutrophils in the non-ECRS with NPs (E) or in the non-ECRS without NPs (F) groups. Scale bar = 20 µm.
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significantly high preoperative total Lund–Mackay CT score and a high proportion of peripheral blood eosino-
phils (r = 0.510, p = 0.009 and r = 0.795, p < 0.0001; Fig. 4A,B, respectively). In particular, a significant negative 
correlation was observed between the level of olfactory function and the EET-releasing eosinophils (r = −0.653, 
p < 0.0001; Fig. 4C). The number of tissue-infiltrating eosinophils and EET-releasing eosinophils tended to be 
higher in patients with comorbid of bronchial asthma compared to those without; however, the difference was 
not statistically significant (total number of tissue eosinophils: 48.8 ± 9.9 vs. 24.7 ± 8.1, p = 0.186, EET-releasing 
eosinophils: 4.5 ± 0.5 vs. 2.9 ± 0.7, p = 0.257; Fig. 4D). None of the other clinical variables including the taste 
test results and postoperative endoscopic findings were significantly different with regard to the number of 
EET-releasing eosinophils in this study.
Discussion
The application of precision medicine in the field of CRS can be more effective after establishing the endotype. 
This is because CRS involves a diverse spectrum of inflammatory diseases showing high heterogeneity, which 
causes different therapeutic responses. Although eosinophil activation in inflamed foci is involved in the patho-
genesis of ECRS, the factors that perpetuate the inflammation are not completely understood.
The present study demonstrates that some eosinophils in the inflamed nasal mucosa in both ECRS and 
non-ECRS patients form EETs, which consist of released filamentous chromatin structures in conjunction with 
eosinophil granule proteins in the extracellular matrix. In the group analysis, the ECRS group had a significantly 
higher presence of EET-releasing eosinophils than did the non-ECRS group, and unsurprisingly, EET formation 
was more often seen when the tissue eosinophils appeared more heavily extended. However, the presence of 
NPs was not a key component for the quantitative difference in EETs. This was a striking finding, since previous 
publications examined only the tissues or secretions from patients with ECRS with NPs12,18,19,25,26. In contrast to 
CRS subjects, none of the control biopsy specimens expressed EETs. EETs were observed mainly in association 
with disruption of the mucosal interface, which may indirectly confirm the findings of previous studies12,16 which 
reported that extracellular polymers are released as a net, similar to a spider-web, and trap invaded bacteria, thus 
participating in the host’s defense against microbes. Taken together, these findings, despite the lack of evidence of 
biological investigations, suggest that EETs might play a role in barrier function of the nasal mucosa via inflam-
mation response in the pathogenesis of CRS, but are not directly related to the tissue remodelling process in NPs.
Possible trigger for the formation of EET in our non-ECRS group remains unclear. Given the subclassification 
of CRS by only using NP status and several preoperative clinical features in this study, it was difficult to sim-
plify and dichotomize heterogeneous inflammation patterns in the comparison between ECRS and non-ECRS 
group. One recent study in the United States depicted that even CRS without NP is comprised of extremely 
diversity of cytokine patterns that 23%, 36%, and 15% of them showed TH1-, TH2-, and TH17-type inflammation, 
respectively, which indicate the overall frequency of type 2 inflammation is higher than type 1 inflammation27. 
In our study, ECRS group evidently had higher number of EET+ eosinophils, while also having high number of 
EET−eosinophils. Compared to non-ECRS, the ratio of EET+/ total eosinophils appears lower (5.1/ 53.6 vs. 0.6/ 
2.5) in ECRS group, although there was no statistically significant difference. Within the limitation of this study, 
we assume that more activated status in eosinophils could be an essential part of the formation of EET rather than 
simply tissue eosinophil counts. This effect was observed in both ECRS and non-ECRS groups, with the majority 
of EETs being focused primarily at the site of epithelial damage. For ECRS group, many eosinophils deposited in 
the basal parts of epithelium or deep in stroma were found to have mostly intact granule, and EET formation was 
much diminished compared to subepithelial region.
Several studies have reported that NETs are linked to various pathologies, including autoimmune inflamma-
tion, infections with thrombosis in sepsis, and allergic diseases9,28. Recently, NETs were identified in bronchial 
biopsies from human asthmatics with a high number of infiltrating neutrophils17. However, no extracellular neu-
trophilic DNA with colocalizing MPO was found in this study. Although, this finding showed similarities with 
Figure 2. Column bar graph illustrating that EET-releasing eosinophils could be found in all CRS subtypes 
(subjects 1–43) but not in healthy control tissues. The proportion of eosinophils releasing EETs was significantly 
higher in ECRS group than in non-ECRS group. However, the presence of NPs exhibited no significant 
differences between CRS groups, which indicates that patients with ECRS may be more easily activated to 
produce EETs regardless of NP status.
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those of the previous publications25, we thought that this result was due to the limited or insufficient number 
of infiltrating neutrophils in our subjects. Further investigations with more tissue samples characterized by a 
neutrophil-dominant cell type and cell-specific knockout approaches may be required to determine the relative 
contribution of NETs to the pathogenesis of CRS.
In the present study, we adapted the JESREC scoring system established by a multicentre study in Japan and 
classified subjects into ECRS and non-ECRS groups using preoperative clinical features of disease side, CT scan, 
presence of NPs, and peripheral blood eosinophils4. Although ECRS is known to more likely be correlated with 
the presence of tissue eosinophilia, there is no agreed-upon standard system for the definition of tissue eosin-
ophilia worldwide. The most important reason for this disagreement is that the distribution of eosinophils is 
typically uneven throughout the tissue. If a certain biomarker is to be used for endotyping, the difference in 
clinical outcome depending on the endotype should be determined. Our study showed that an increased number 
of EET-releasing eosinophils indicated the presence of a greater disease burden with respect to the blood and 
eosinophilia as well as increased CT severity score and decreased olfactory function.
Figure 3. Quantitative analysis of infiltrating eosinophils and EETs according to CRS subtype. (A) The number 
of EET-releasing eosinophils and the total number of tissue eosinophils were significantly higher in the ECRS 
group than in the non-ECRS group. (B) However, the presence of NPs was not associated with EET formation. 
(C) Linear regression analysis between the numbers of EET-forming and total infiltrating eosinophils showed a 
statistically significant positive correlation. The lines indicate the mean with 95% confidence interval.
Figure 4. The extent of EET formation is correlated with (A) preoperative CT score, (B) decreased olfactory 
function, and (C) proportion of peripheral blood eosinophils, (D) but not with presence of asthma. The lines 
indicate the mean with 95% confidence interval.
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These clinical characteristics of EETs may derive from their functional attributes. The expanding DNA traps 
in the inflamed nasal mucosa contribute to the properties of highly viscous eosinophilic mucin and impairments 
in its clearance, resulting in long-lasting inflammation and formation of a secondary epithelial barrier defect15. 
As a result, the odorant might be interfered with the passage from nasal cavity into olfactory nerve of olfactory 
epithelium. Decreased olfaction function in association with EET formation could also suggest a possible role 
for tissue eosinophilia or eosinophil-associated mucous cytokines that induce cell damage at the neuronal level, 
likely from inflammatory infiltrate in CRS-associated olfaction dysfunction29,30. Further studies, including those 
evaluating the possible role of EETs in CRS, should be performed to designate new biomarkers that could reflect 
activated eosinophils with a greater disease burden.
In summary, in this study, we describe the presence and clinical characteristics of EETs representing a novel 
feature of activated eosinophils infiltrating the nasal mucosa in both ECRS and non-ECRS subjects in vivo. The 
concept of EETs also could have novel implications for potential therapeutic targets, clinical decision-making, and 
prediction of treatment outcome.
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